dc.contributor.advisor |
Bester, Megan J. |
en |
dc.contributor.postgraduate |
Green, Pieter-Hendrik |
en |
dc.date.accessioned |
2013-09-07T12:53:06Z |
|
dc.date.available |
2005-09-23 |
en |
dc.date.available |
2013-09-07T12:53:06Z |
|
dc.date.created |
2003-09-10 |
en |
dc.date.issued |
2005-09-23 |
en |
dc.date.submitted |
2005-09-22 |
en |
dc.description |
Dissertation (MSc (Chemical Pathology))--University of Pretoria, 2005. |
en |
dc.description.abstract |
Please read the abstract in the section 00front of this document |
en |
dc.description.availability |
unrestricted |
en |
dc.description.department |
Chemical Pathology |
en |
dc.identifier.citation |
Green P-H, 2003, The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols, MSc dissertation, University of Pretoria, Pretoria, viewed yymmdd < http://hdl.handle.net/2263/28108 > |
en |
dc.identifier.other |
H1184/th |
en |
dc.identifier.upetdurl |
http://upetd.up.ac.za/thesis/available/etd-09222005-111752/ |
en |
dc.identifier.uri |
http://hdl.handle.net/2263/28108 |
|
dc.language.iso |
|
en |
dc.publisher |
University of Pretoria |
en_ZA |
dc.rights |
© 2003 University of Pretoria. All rights reserved. The copyright in this work vests in the University of Pretoria. No part of this work may be reproduced or transmitted in any form or by any means, without the prior written permission of the University of Pretoria. |
en |
dc.subject |
Genetic polymorphisms |
en |
dc.subject |
Caucasian race south africa |
en |
dc.subject |
Anticoagulants medicine |
en |
dc.subject |
Warfarin |
en |
dc.subject |
UCTD |
en_US |
dc.title |
The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols |
en |
dc.type |
Dissertation |
en |